Multifocal Motor Neuropathy with Conduction Blocks During TNF-alpha Antagonist Therapy in a Patient with Spondyloarthropathy
Journal of Rheumatic Diseases
;
: 177-180, 2013.
Article
in Korean
| WPRIM
| ID: wpr-107355
ABSTRACT
Tumor necrosis factor (TNF)-alpha antagonist has been proven to have benefit for rheumatologic diseases. Because TNF-alpha is not only an important mediator of inflammation in human body, but plays many physiologic roles, it can cause unique adverse effects or complications related to these functions. Adverse effects involving neurological systems, such as Guillain-Barre syndrome, Chronic inflammatory demyelinating polyneuropathy, multifocal motor neuropathy with conduction blocks (MMNCB), distal symmetric polyneuropathy, and small fibers neuropathy have been previously reported. However, only several cases of infliximab-associated MMNCB are reported. We report a case of MMNCB which developed while treating spondyloarthropathy with infliximab.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Polyneuropathies
/
Tumor Necrosis Factor-alpha
/
Human Body
/
Guillain-Barre Syndrome
/
Spondylarthropathies
/
Infliximab
/
Inflammation
/
Antibodies, Monoclonal
Limits:
Humans
Language:
Korean
Journal:
Journal of Rheumatic Diseases
Year:
2013
Type:
Article
Similar
MEDLINE
...
LILACS
LIS